CELLPLY

cellply-logo

Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization of cancer immunotherapies, cell therapies and cell-based biotherapeutics. The company aims to support the development of novel cancer immunotherapies by accelerating R&D, automating the quality control and advancing the ability to monitor the clinical response to these treatments. Through the use of proprietary microfluidic technologies with Co-Culture Array technology, highly-automated analytical instruments and AI-powered image and data analytics, Cellply products define the function of the immune system one cell at a time, combining functional data with other multiplex data and providing unprecedented single-cell analytical solutions.

#SimilarOrganizations #People #Financial #Website #More

CELLPLY

Social Links:

Industry:
Biotechnology Health Care Medical

Founded:
2013-01-01

Address:
Bologna, Emilia-Romagna, Italy

Country:
Italy

Website Url:
http://www.cellply.com

Total Employee:
11+

Status:
Active

Contact:
+390510397670

Email Addresses:
[email protected]

Total Funding:
6.69 M EUR

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome


Similar Organizations

igeneon-logo

Igeneon

Igeneon specializes in cancer immunotherapy.

nuchem-sciences-logo

NuChem Sciences

NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montrรฉal and Lรฉvis.

slingshot-biosciences-logo

Slingshot Biosciences

Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.

surface-oncology-logo

Surface Oncology

Surface Oncology develops next-generation cancer immunotherapy treatments based on proprietary discoveries.

tango-therapeutics-logo

Tango Therapeutics

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

verismo-therapeutics-logo

Verismo Therapeutics

Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.


Current Advisors List

antonio-leone_image

Antonio Leone Board Member @ CellPly
Board_member
2014-01-01

Current Employees Featured

massimo-bocchi_image

Massimo Bocchi
Massimo Bocchi CEO & Co-Founder @ CellPly
CEO & Co-Founder
2014-01-01

not_available_image

Roberto Guerrieri
Roberto Guerrieri Senior Founder @ CellPly
Senior Founder
2013-01-01

not_available_image

Michele Federici
Michele Federici Full Stack Developer @ CellPly
Full Stack Developer
2017-05-01

Founder


massimo-bocchi_image

Massimo Bocchi

not_available_image

Roberto Guerrieri

Investors List

italian-angels-for-growth_image

Italian Angels for Growth

Italian Angels for Growth investment in Venture Round - CellPly

liftt_image

LIFTT

LIFTT investment in Venture Round - CellPly

rearden-capital-management-llc_image

Rearden Capital Management LLC

Rearden Capital Management LLC investment in Venture Round - CellPly

metaventures_image

Metaventures

Metaventures investment in Venture Round - CellPly

indaco-venture-partners_image

Indaco Venture Partners

Indaco Venture Partners investment in Venture Round - CellPly

horizon-2020_image

Horizon 2020

Horizon 2020 investment in Grant - CellPly

easme_image

EASME - EU Executive Agency for SMEs

EASME - EU Executive Agency for SMEs investment in Grant - CellPly

ingenium-emilia-romagna_image

INGENIUM Emilia Romagna

INGENIUM Emilia Romagna investment in Seed Round - CellPly

indaco-venture-partners_image

Indaco Venture Partners

Indaco Venture Partners investment in Seed Round - CellPly

italian-angels-for-growth_image

Italian Angels for Growth

Italian Angels for Growth investment in Seed Round - CellPly

Official Site Inspections

http://www.cellply.com

  • Host name: 27-152-172-163.instances.scw.cloud
  • IP address: 163.172.152.27
  • Location: France
  • Latitude: 48.8582
  • Longitude: 2.3387
  • Timezone: Europe/Paris

Loading ...

More informations about "CellPly"

About Us | CELLPLY

Cellply is a deep tech company with the ambition to develop analytical tools enabling fast end effective development of life-saving cancer cell therapies. Our solutions support biopharma โ€ฆSee details»

CellPly - Crunchbase Company Profile & Funding

Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization of cancer immunotherapies, cell therapies and cell-based โ€ฆSee details»

Welcome to CellPly's Recruiting Process Procedure

Recruiting Process Procedure As an organization dedicated to fostering innovation and excellence, we recognize that our most valuable asset is our people. Attracting, selecting, and โ€ฆSee details»

CellPly Company Profile - Office Locations, Competitors ... - Craft

CellPly has 5 employees across 2 locations and $5.92 m in total funding,. See insights on CellPly including office locations, competitors, revenue, financials, executives, subsidiaries and more โ€ฆSee details»

CellPly 2025 Company Profile: Valuation, Funding & Investors

Information on valuation, funding, cap tables, investors, and executives for CellPly. Use the PitchBook Platform to explore the full profile.See details»

CellPly - Funding, Financials, Valuation & Investors - Crunchbase

CellPly is funded by 10 investors. RECOMEC and Schia Ventures are the most recent investors.See details»

CELLPLY - LIFTT

Dec 15, 2021 CellPly is a company specializing in pioneering life-science analytical tools. The goal of the investment is to complete the development and bring to the market an innovative analytical platform to deeply characterize โ€ฆSee details»

CellPly - Contacts, Employees, Board Members, Advisors & Alumni

CellPly has 4 current employee profiles, including Senior Founder Roberto Guerrieri. CellPly has 1 board member or advisor, Antonio Leone.See details»

CellPly Company Information - Funding, Investors, and More

Get information on funding, investors, industries, and more for CellPly. See CellPly company profile and funding data.See details»

Cellply | F6S

Cellply - Only 1 out of 4 oncology drugs provides a benefit to the patient, despite the fact that global healthcare expenditure for oncology drugs has reached $100b yearly. Every cancer โ€ฆSee details»

Products - CELLPLY

VivaCyte platform includes proprietary disposable microfluidic devices, standalone instrument for sample prep and cell analysis, software for workflow configuration and automated image โ€ฆSee details»

CellPly - Products, Competitors, Financials, Employees, โ€ฆ

CellPly focuses on developing analytical tools for cancer immunotherapies, cell therapies, and cell-based biotherapeutics. The company offers the VivaCyte platform, an analytical system โ€ฆSee details»

CellPly - Overview, News & Similar companies | ZoomInfo.com

Jan 17, 2024 View CellPly (www.cellply.com) location in Emilia-Romagna, Italy , revenue, industry and description. Find related and similar companies as well as employees by title and โ€ฆSee details»

Cellply Company Overview, Contact Details & Competitors | LeadIQ

Learn more about Cellply's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»

CellPly - Updates, News, Events, Signals & Triggers - Crunchbase

Number of Articles 2 Newsโ€ขNov 17, 2022 Biospace โ€” Cellply appoints Alessia Zanelli as the new Chair of the Board Funding Roundโ€ขDec 15, 2021 CellPly raised โ‚ฌ2,000,000 / Series Unknown โ€ฆSee details»

Cellply launches its end-to-end single cell potency characterization ...

Jan 17, 2024 Integrates potency analysis and immunophenotyping to streamline cell therapy R&D Fully automated, standalone platform with single-cell resolution BOLOGNA, Italy, โ€ฆSee details»

Applications | CELLPLY

A single immune cell can be evaluated for immunophenotype and ability to kill two or more target cells within a time lapsed study. Leveraging this protocol, the CC-Array technology allows โ€ฆSee details»

Cellply โ€“ Fesr programme 2021-2027 | CELLPLY

Cellply is a company that develops analytical instruments for the pharmaceutical and life science industries. Cellply has developed the new VivaCyte® platform, the first applications of which โ€ฆSee details»

Launch of VivaCyte® at Advanced Therapies Week 2024 | CELLPLY

Advanced Therapies Week is the annual conference where new technologies and techniques are showcased that have the potential to revolutionize ways to develop, manufacture and โ€ฆSee details»

linkstock.net © 2022. All rights reserved